Ten years ago, Oracle (NYSE: ORCL) and Salesforce (NYSE: CRM) were both navigating a pivotal shift: legacy software companies racing to reinvent themselves as cloud businesses. Both made it, but the ...

Oracle posted earnings that topped Wall Street estimates and lifted its outlook, as strong AI demand drove its sales and ...

The expanded fund, disclosed in a filing with the US Securities and Exchange Commission following Oracle's quarterly earnings report, has heightened concerns that the company's restructuring ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Free cash flow at the enterprise software giant has tumbled over the past year as the company races to spend $50 billion on AI.

Oracle's Mike Sicilia is the latest software CEO to wade in to the debate on whether artificial intelligence tools that heavily automate human tasks will mean the demise of his industry. His verdict ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...